Evidence map›Paper›PMID 38167605›Full record

ArticleBMJ open diabetes research & care2024

High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practice.

Katrina Tibballs, Anne Karen Jenum, Lars Kirkebøen, Tore Julsrud Berg, Tor Claudi, John Graham Cooper, Kjersti Nøkleby, Sverre Sandberg, Jørund Straand, Esben Selmer Buhl

Abstract read
In one paragraph

Article in BMJ open diabetes research & care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katrina TibballsDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway k.l.b.tibballs@medisin.uio.no.ORCID 0000-0002-0468-3182
Anne Karen JenumDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.ORCID 0000-0003-0304-7800
Lars KirkebøenStatistics Norway, Oslo, Norway.
Tore Julsrud BergFaculty of Medicine, University of Oslo, Oslo, Norway.
Tor ClaudiNordlandssykehuset, Bodø, Norway.
John Graham CooperNorwegian Organization for Quality Improvement of Laboratory Examinations, Bergen, Norway.
Kjersti NøklebyDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.ORCID 0000-0001-9806-8668
Sverre SandbergNorwegian Organization for Quality Improvement of Laboratory Examinations, Bergen, Norway.
Jørund StraandDepartment of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
Esben Selmer BuhlGeneral Practice Research Unit, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople with young-onset type 2 diabetes (YOD), defined as diabetes diagnosis before age 40, have a high lifetime risk of vascular complications. We aimed to estimate the prevalence of YOD among adults with type 2 diabetes (T2D) in Norwegian general practice and explore associations between age at diabetes diagnosis and retinopathy overall and in men and women. RESEARCH DESIGN AND

methodsWe collected cross-sectional data from general practice electronic medical records of 10 241 adults with T2D in 2014, and repeated measurements of hemoglobin A

resultsOf all individuals with T2D, 10% were diagnosed before 40 years of age in both sexes. Compared with later-onset T2D, HbA

conclusionsRetinopathy prevalence was more than twice as high in YOD as in later-onset T2D. The increased likelihood of retinopathy in YOD was partly mediated by higher HbA

Indexed as

Diabetes Mellitus, Type 2General PracticeRetinal DiseasesAdultCross-Sectional StudiesFemaleHumansMalePrevalenceSex CharacteristicsAge of OnsetDiabetes Mellitus, Type 2Diabetic RetinopathyPrimary Care

Identifiers

PMID38167605
PMCPMC10773319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.